Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Study of Micafungin in Patients With Invasive Candidiasis or Candidemia

ClinicalTrials.gov ID: NCT00105144

Public ClinicalTrials.gov record NCT00105144. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 12:08 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Comparative Study of Micafungin (FK463) Versus Caspofungin as Antifungal Treatment in Patients With Invasive Candidiasis or Candidemia

Study identification

NCT ID
NCT00105144
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Astellas Pharma Inc
Industry
Enrollment
611 participants

Conditions and interventions

Interventions

  • Micafungin Drug
  • Caspofungin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2004
Primary completion
Mar 31, 2006
Completion
Mar 31, 2006
Last update posted
Sep 17, 2014

2004 – 2006

United States locations

U.S. sites
62
U.S. states
29
U.S. cities
52
Facility City State ZIP Site status
Not listed Birmingham Alabama 35294
Not listed Little Rock Arkansas 72205
Not listed Los Angeles California 90033
Not listed Los Angeles California 90095
Not listed San Francisco California 94115
Not listed Denver Colorado 80204
Not listed Denver Colorado 80262
Not listed Washington D.C. District of Columbia 20010
Not listed Bay Pines Florida 33744
Not listed Miami Florida 33136
Not listed Atlanta Georgia 30322
Not listed Augusta Georgia 30909
Not listed Augusta Georgia 30912
Not listed Chicago Illinois 60612
Not listed Chicago Illinois 60637
Not listed Maywood Illinois 60153
Not listed Beech Grove Indiana 46107
Not listed Evansville Indiana 47714
Not listed Des Moines Iowa 50309
Not listed Iowa City Iowa 52242
Not listed Kansas City Kansas 66160
Not listed Wichita Kansas 67214
Not listed Lexington Kentucky 40536
Not listed New Orleans Louisiana 70121
Not listed Baltimore Maryland 21201
Not listed Baltimore Maryland 21287
Not listed Boston Massachusetts 02111
Not listed Boston Massachusetts 02115
Not listed Boston Massachusetts 02215
Not listed Detroit Michigan 48201
Not listed Detroit Michigan 48202
Not listed Minneapolis Minnesota 55455
Not listed Jackson Mississippi 39216
Not listed St Louis Missouri 63310
Not listed Neptune City New Jersey 07754
Not listed Albany New York 12208
Not listed Manhasset New York 11030
Not listed New Hyde Park New York 11040
Not listed New York New York 10029
Not listed New York New York 10032
Not listed Rochester New York 14642
Not listed Stony Brook New York 11794
Not listed The Bronx New York 10467
Not listed Valhalla New York 10595
Not listed Durham North Carolina 27710
Not listed Winston-Salem North Carolina 27157
Not listed Cincinnati Ohio 45267
Not listed Columbus Ohio 43210
Not listed Allentown Pennsylvania 18103
Not listed Philadelphia Pennsylvania 19104
Not listed Philadelphia Pennsylvania 19140
Not listed Pittsburgh Pennsylvania 15213
Not listed West Reading Pennsylvania 19611
Not listed Providence Rhode Island 02908
Not listed Jackson Tennessee 38301
Not listed Memphis Tennessee 38104
Not listed Dallas Texas 75246
Not listed Houston Texas 77030
Not listed San Antonio Texas 78229
Not listed Charlottesville Virginia 22908
Not listed Fairfax Virginia 22030
Not listed Seattle Washington 98109

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 105 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00105144, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 17, 2014 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00105144 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →